Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 459-330-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 07/11/2018 - 12/06/2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- yes
- Remarks:
- Discussed in "Principles of Method if Other Than Guideline"
- Principles of method if other than guideline:
- 1 - Molecular weight of the test substance
The molecular weight of the test substance was described in the information obtained from industry group as 294.0. The test atmosphere was generated during 1st–8th exposure based on this information. The correct molecular weight was 200.05. Exposure concentration was calculated by the correct molecular weight in all exposure. The study results were evaluated by the correct exposure concentration and it was concluded that the study reliability was secured.
2 - Number of animals in the cage during the quarantine period
Since one female was euthanised, one female (animal No. 59033) housed in the same cage was individually housed in a cage from the day after the animal receipt to the end of the quarantine period. This female was allocated to the study group after the acclimatisation period for 2 weeks and it was concluded that the individual housing did not affect the animal health condition.
3 - Exposure concentration
On the exposure concentration analysis, the peak retention time shifted on the analysis of the sample at 3 hours after the start of exposure in the 1000 ppm group on Day 57. The GC was used in another study with different column temperature. The setting of the temperature was returned for this study, and the analysis was carried out after confirmation the temperature indication to the prescribed level. However, it was estimated that the actual temperature did not reach the prescribed level, this resulted in the shift of the peak retention time. It was judged that the analysis was not reliable as a result. Since other time points were reliable and concentrations were stable over time, it was concluded that this deviation did not affect the study reliability.
4 - Subject pups on blood chemistry
In the study protocol, it was described that 1 male and 1 female per litter would be subjected to blood chemistry evaluation. It was defined that the eliminated pups were subjected to blood chemistry in the section for litter size in the study protocol. Inconsistent description resulted in the deviation from the study protocol. Since the subject pups were selected depending on the number of sex on day 4 of lactation, the pups with one sex only were subjected to the examination in a few animals. The study reliability was not affected because the subject of examination could be identified from overall description of the study protocol.
5 - Sample volume of blood chemistry
The blood sampling was conducted in one pup and in two parental females (animal Nos.50204 and 50404) - the blood sample volumes were less than 0.4 mL. Though the volume was inconsistent with the study protocol, measurement of blood chemistry could be conducted in these animals and reliability of study was secured. - GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether
- EC Number:
- 609-858-6
- Cas Number:
- 406-78-0
- Molecular formula:
- C4H3F7O
- IUPAC Name:
- 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- Lot No. 51807130
Purity 99.98%
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Details on species / strain selection:
- This strain is widely used in reproductive and developmental toxicity study using rodents, and there are abundant historical data.
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals were acclimatised from receipt until the beginning of the testing. At the beginning of this time, they were quarantined for 5 days. Observations taken during this period included a clinical observation, body weight measurements and estrous cycle measurements.
Animals were housed in a temperature range of 21.8 - 25.0°C; a relative humidity range
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure (if applicable):
- whole body
- Vehicle:
- air
- Details on exposure:
- Rats were individually housed in a wire-mesh cage. The cage was put into the inhalation chamber, which ensured air ventilation. The start of exposure in the test group was defined as the point at which the test substance reached equilibrium. The start of exposure in the control group was defined at 18 minutes after the door closing, which was equivalent to the time taken to reach 95% atmosphere equilibrium (t95). End of exposure was defined as 6 hours after the start of exposure.
- Details on mating procedure:
- 1:1 (1 male and 1 female) mating was used in this study. The female was placed with the same male day and night from the evening on day 15 (the first day of mating) for a maximum of 14 days except during exposure. Every morning, the females were examined via vaginal smear. Day 0 of gestation was defined as the day a vaginal plug or sperm was found. The following parameters were calculated:
(1) Number of days until copulation: Days from start of mating to copulation confirmation
(2) Copulation index (%): (Number of copulated males or females/number of pairs) × 100
(3) Fertility index (%): (Number of pregnant males or females/number of copulated males or females) × 100 - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Analytical verification of doses was performed using a Shimadzu Corp. GC-14B Gas Chromatography machine. The injection temperature was 150°C, and column temperature was 60°C.
- Duration of treatment / exposure:
- 6 hours
- Frequency of treatment:
- 35 days total
- Details on study schedule:
- Exposure started approximately 14 days before the start of the mating period, and lasted until the day before necropsy.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 ppm (nominal)
- Dose / conc.:
- 500 ppm (nominal)
- Dose / conc.:
- 4 089.5 mg/m³ air (nominal)
- Dose / conc.:
- 1 000 ppm (nominal)
- Dose / conc.:
- 8 179 mg/m³ air (nominal)
- Dose / conc.:
- 1 500 ppm (nominal)
- Dose / conc.:
- 12 269 mg/m³ air (nominal)
- No. of animals per sex per dose:
- 12
- Control animals:
- yes, concurrent vehicle
Examinations
- Parental animals: Observations and examinations:
- 1:1 (1 male and 1 female) mating was used in this study. The female was placed with the same male day and night from the evening on day 15 (the first day of mating) for a maximum of 14 days except during exposure. Every morning, the females were examined via vaginal smear. Day 0 of gestation was defined as the day a vaginal plug or sperm was found. The following parameters were calculated:
(1) Number of days until copulation: Days from start of mating to copulation confirmation
(2) Copulation index (%): (Number of copulated males or females/number of pairs) × 100
(3) Fertility index (%): (Number of pregnant males or females/number of copulated males or females) × 100
Day 0 of lactation was defined as the day of delivery. The parental females were observed for maternal behavior, including lactation, nest building, and cannibalism until 13 days after delivery (day 13 of lactation). - Oestrous cyclicity (parental animals):
- Estrous cycle of the females in each group was examined by vaginal smear sampling in the morning from the day of start dosing to the day confirmed copulation or end of mating period in the females not confirmed mating. Estrous cycle was classified the stage of diestrus (D), proestrus (P), estrus (E), and metestrus (M). The count of estrous and estrous cycle were calculated. Moreover, estrous cycle was determined at day 13 of lactation by vaginal smear sampling.
- Sperm parameters (parental animals):
- The testes were fixed and preserved in 10vol% phosphate-buffered formalin, fixed with Bouin’s solution and preserved in 10vol% phosphate-buffered formalin. In the dead animal, all organs and tissues were fixed and preserved in 10vol% phosphate-buffered formalin. (2) Preparation of specimen and microscopic examination. In the control group and high concentration exposure group, hematoxylin and eosin stained specimens were prepared according to the routine method. Moreover, the testes were processed to PAS stained specimen. The histopathological specimens were microscopically examined. The testes were microscopically examined with identification of stages of seminiferous tubule based on spermatogenesis cycle.
- Litter observations:
- All live pups were individually weighed on postnatal days 0, 4, and 13 after birth with an electrical balance (PB3002-S: Mettler-Toledo K.K.).
Anogenital distance (AGD) of the pups after litter size adjustment was measured with a vernier caliper on postnatal day 4 after birth. The AGD was normalized by the cube root
of body weight on the day of AGD measurement.
The number of nipple/areola was counted in all male pups on day 12 after birth, and the following parameter was calculated.
Nipple development index: (Number of abnormal male pups retaining nipples/number of examined male pups) × 100 - Postmortem examinations (parental animals):
- The following organs/tissues were collected and weighted:
Thyroids/parathyroids, testes, epididymides, levator ani/bulbocavenosus muscle complex, cowper's glands, glans penis, ovaries
They were weighed on the scheduled necropsy with an electrical balance (AW120: Shimadzu Corp.). The bilateral organs were weighed simultaneously for both sides. The thyroid/parathyroid was weighed after fixation with formalin. Moreover, relative organ weight (body weight-relative) was calculated from body weight measured on the day of necropsy. No measurement was conducted in the dead animal.
The following organs/tissues were examined via histopathology:
Testes, epididymides, ovaries, uterus
The collected organs and tissues were fixed and preserved in 10vol% phosphate-buffered formalin. The testes and epididymis were fixed with Bouin’s solution and preserved in 10vol% phosphate-buffered formalin. In the dead animal, all organs and tissues were fixed and preserved in 10vol%
phosphate-buffered formalin. (2) Preparation of specimen and microscopic examination. In the control group and high concentration exposure group, hematoxylin and eosin stained specimens were prepared according to the routine method. Moreover, the testes were processed to PAS stained specimen. The histopathological specimens were microscopically examined. The testes were microscopically examined with identification of stages of seminiferous tubule based on spermatogenesis cycle. - Postmortem examinations (offspring):
- All offspring were examined externally for gross abnormalities including oral cavity on postnatal day 13. Thereafter, head, organs and tissues in the thorax and abdominal cavities were observed for gross abnormalities after euthanisation according to the same method as parental animals. The thyroids of 1 male and 1 female pups per litter were fixed and preserved in 10 vol% phosphate-buffered formalin. External anomalies were examined in dead offspring. The following indexes for external anomalies were calculated. External anomaly by type retention index was not calculated according to the study results.
(1) External anomalies retention index: (Number of pups indicating external anomaly/number of pups examined) × 100
(2) External anomalies by type retention index: (Number of pups indicating external anomaly by type/number of pups examined) × 100 - Statistics:
- The following statistical analyses were conducted. Safety Study System (tsPharma LabSite: Fujitsu Ltd.) was used in the statistical analyses. The statistical analysis system (EXSUS: CAC Croit Corp.) and SAS system (SAS Institute Inc.) were used in the analysis which did not use the Safety Study System. In the data on offspring, the data calculated in each litter were used in the analysis.
Multiple comparison test
In the following parameters, variance was assessed using Bartlett’s test (significant level: 5%). When the variance was homogeneous, multiple comparison test was conducted according to Dunnett’s test. Otherwise, multiple comparison test was conducted according to Steel’s test. Significance levels were set at 1% and 5%. Body weight, body weight gain, food consumption, organ weight, body weight-relative organ weight, estrous cycle, number of estrous cycle, days required for copulation, duration of gestation, number of implantation, number of offspring (live pups and stillbirth pups), body weight of pups in each sex, AGD, blood chemistry
X2 test
In the following parameters, statistical analysis was performed between the control group and groups exposed the test substance. Copulation index, fertility index, delivery index, sex ratio
Wilcoxon rank-sum test
In the following parameters, statistical analysis was performed between the control group and groups exposed the test substance.
Stillborn index, external anomalies retention index, delivery index, birth index, viability on days 4 and 13, male nipple development index - Reproductive indices:
- Numbers of implantations were examined in the ovaries and uterus obtained from the parental females at necropsy. The following parameters were calculated from the examination results.
(1) Duration of gestation: From day 0 of gestation to completion of delivery
(2) Gestation index (%): (Total number of delivered females/total number of pregnant) ×
100
(3) Delivery index (%): (Number of pups/number of implantation) × 100 - Offspring viability indices:
- Number of pups (stillbirth and live birth), sex, and external abnormalities (including runts) were examined on day 0 of lactation. Thereafter, they were observed daily in clinical signs and mortality. The following parameters were calculated from the observation results.
(1) Birth index: (Number of live pups/number of implantation) × 100
(2) Stillborn index: (Number of stillborn pups/total number of pups) × 100
(3) Viability on day 4:
(number of live pups on day4/total number of pups at birth) × 100
(4) Viability on day 13:
(number of live pups on day 13/ number of live pups on day 4) × 100
(5) Sex ratio: (Male pups/total number of pups) × 100
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Mass on chest in 1 female at 4089.5 mg/m3 (500 ppm), no dose-response observed suggesting no test substance related finding
- Dermal irritation (if dermal study):
- not examined
- Mortality:
- mortality observed, non-treatment-related
- Description (incidence):
- 1 male died day 9 at 12268.5 mg/m3 (1500 ppm)
- Body weight and weight changes:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Statistically significant decreased bodyweight gain in females day 7 of lactation period at 4089.5 mg/m3 (500ppm), in males day 8 at 8179 mg/m3 (1000ppm), in males day 8 and females day 7 of gestation, and day 7 of lactation at 12268.5 mg/m3 (1500ppm)
Increased bodyweight gain in females day 8 at 12268.5 mg/m3 (1500ppm) - Food consumption and compound intake (if feeding study):
- effects observed, non-treatment-related
- Description (incidence and severity):
- Statistically significant low value in males day 1 at 12268.5 mgm3 (1500ppm)
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- no effects observed
- Description (incidence and severity):
- No statistically significant effect on blood T4 levels in males or pups
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- No effect on organs
- Histopathological findings: neoplastic:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Macroscopic cutaneous mass (adenocarcinoma) of mammary gland in 1 female at 4089.5 mg/m3 (500 ppm), considered spontaneous change
- Other effects:
- not examined
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- effects observed, non-treatment-related
- Description (incidence and severity):
- Statistically significant decrease in count of estrus in females at 12268.5 mg/m3 (1500ppm)
Statistically significant increase in estrus cycle (day) in females at 12268.5 mg/m3 (1500ppm)
The actual concentration in the 12269 mg/m3 (1500ppm) group was more than 16358 mg/m3, or 2000 ppm (16930.53-20202.13 mg/m3, or 2070–2470 ppm). No differences were noted between the control group and 8179 mg/m3 (1000 ppm) group exposed to the actual concentration of 11123.44-13086.4 mg/m3 (1360-1600 ppm) - Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- effects observed, non-treatment-related
- Description (incidence and severity):
- All females showed evidence of copulation
No statistically significant effect in reproductive parameters, eg, number of days until copulation, copulation index, and fertility index
Statistically significant decreased delivery index and birth index values at 4089.5 mg/3 (500ppm)- no exposure concentration-dependencies observed, not attributable to test substance
No statistically significant effect on parameters to do with results of delivery and observation of lactation, eg, duration of gestation, delievery index, or birth index.
Effect levels (P0)
open allclose all
- Key result
- Dose descriptor:
- NOEC
- Effect level:
- > 1 500 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Key result
- Dose descriptor:
- NOEC
- Effect level:
- > 12 268.5 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Target system / organ toxicity (P0)
- Key result
- Critical effects observed:
- no
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No effect on clinical signs or abnormalities
No effect on external anomalies - Dermal irritation (if dermal study):
- not examined
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- No effect on indices such as stillborn index or viability index
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- No statistically significant effect on body weight
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- not examined
- Histopathological findings:
- no effects observed
- Description (incidence and severity):
- No change observed in necropsy
- Other effects:
- not examined
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not examined
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not examined
Effect levels (F1)
open allclose all
- Key result
- Dose descriptor:
- NOEC
- Generation:
- F1
- Effect level:
- > 1 500 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Key result
- Dose descriptor:
- NOEC
- Generation:
- F1
- Effect level:
- > 12 268.5 mg/m³ air (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Target system / organ toxicity (F1)
- Key result
- Critical effects observed:
- no
Overall reproductive toxicity
open allclose all
- Reproductive effects observed:
- no
- Lowest effective dose / conc.:
- 1 500 ppm
- Treatment related:
- no
- Reproductive effects observed:
- no
- Lowest effective dose / conc.:
- 12 268.5 mg/m³ air
- Treatment related:
- no
Applicant's summary and conclusion
- Conclusions:
- It was concluded that the no observed adverse effect level (NOAEL) of reproduction/developmental toxicity of 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether is greater than 12268.5 mg/m3 (1500 ppm) for males and females.
- Executive summary:
A reproduction/developmental toxicity screening test of 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether (HFE-347pc-f) was conducted using Crl:CD(SD) rats in accordance with the OECD guidelines for the testing chemicals (No. 421) by inhalation exposure.
The actual exposure concentrations were 4580.24, 9078.69, and 13822.51 mg/m3 (560, 1110, and 1690 ppm).
The test substance exposure to the parental animals resulted in no toxicological significance changes. No abnormalities were found in clinical observation, no toxicological significant differences among the groups in body weight, body weight gain, food consumption, or plasma T4 level. Moreover, the test substance exposure did not result in changes in the reproductive functions. No differences among the groups were noted in estrous cycle, days required for copulation, copulation index, fertility index, duration of gestation, delivery index, or birth index. Moreover, no visible histopathological changes were found in any animals.
The test substance exposure did not show developmental toxicity. Body weight of offspring did not show differences among the groups. No abnormalities were noted in the external or clinical observation of offspring. No differences among the groups were noted in birth index, stillborn index, viability index, or sex ratio. Anogenital distance was not change among the groups. No nipple was observed in any male pups. There were no changes in the necropsy of offspring conducted after 4 days of lactation. From the above results, it was concluded that the no observed adverse effect level (NOAEL) of reproduction/developmental toxicity of 1,1,2,2-tetrafluoroethyl-2,2,2-trifluoroethyl ether is greater than 12268.5 mg/m3 (1500 ppm) for males and females.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.